ADVANCED UROTHELIAL CARCINOMA
Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted therapy trial offers hope for advanced bladder cancer patients
Disease control Recruiting nowThis study is testing whether a targeted cancer drug called trastuzumab rezetecan works better alone or combined with an immunotherapy drug called adebrelimab for advanced bladder cancer that has spread. The trial will enroll 96 adults whose cancer has a specific marker called HE…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New Two-Step attack on advanced bladder cancer
Disease control Recruiting nowThis study is testing a two-part treatment for people with advanced bladder cancer that has spread. First, patients receive a combination of two drugs for about 4 months. If the cancer responds, they then continue with one of the drugs as a long-term 'maintenance' therapy for up …
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First patients to test new pill for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people to test a new oral drug called FX-909. It aims to find a safe dose and see how well the body handles it, both alone and when combined with an existing immunotherapy drug (pembrolizumab). The study is for adults with advanced solid tumors that hav…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC